In Beji A's study, the strong presence of membranous HER3 indicated a higher risk of tumor-associated death (HR 3.29, P< 0.05), establishing HER3 as a putative novel independent prognostic marker for colorectal cancer [22]. This evidence concerns the gene ERBB3 and colorectal cancer.